2023 Recap
SAN DIEGO, Calif. – February 28, 2024 – We are extremely proud of our significant accomplishments from the past year.Read More
SAN DIEGO, Calif. – February 28, 2024 – We are extremely proud of our significant accomplishments from the past year.Read More
Methamphetamine Use Reaches All-Time High in People Who Use Fentanyl with No Signs of Slowing, Adding Fuel to U.S. Fentanyl Crisis
Millennium Health Signals Report™ illustrates changing nature of polysubstance use
SAN DIEGO, Calif. – February 21, 2024 – According to Millennium Health’s Signals Report, a staggering 60% of specimens in 2023 from patients who have used fentanyl also contained methamphetamine, an increase of 875% since 2015.Read More
SAN DIEGO, Calif. – February 20, 2024 – In our efforts to raise awareness of the dangers of fentanyl and other illicit drugs, we regularly work with the media to share information nationally and within our local communities. Read More
Millennium Health Signals Alert™ Shows Reemergence of Deadly Carfentanil
Carfentanil detections in urine drug tests have increased from coast to coast in 2023 and may exacerbate the nation’s overdose crisis
SAN DIEGO, Calif. – November 2, 2023 – Carfentanil is one of the most potent fentanyl analogues known; 100 times more potent than fentanyl and 10,000 times more potent than morphine.Read More
Xylazine Has Spread to Every Region of the Country, Millennium Health Signals Report™ Shows
Xylazine, fentanyl and other potentially lethal substances frequently found together, report from more than 160,000 urine drug tests demonstrates
SAN DIEGO, Calif. – September 14, 2023 – According to the Millennium Health Signals Report released today, the powerful, veterinary tranquilizer xylazine—also known as “tranq”—was detected in urine drug tests from every region of the country, with the highest rates in the Eastern U.S. This analysis of the nationwide spread of xylazine is the most current and substantiative to date since xylazine use rose to prominence.Read More
Millennium Health Signals Alert™ Identifies Surge of Parafluorofentanyl in the Western U.S.
Clinicians and public health officials in the West should maintain awareness of parafluorofentanyl use in their communities
SAN DIEGO, Calif. – September 11, 2023 – According to an analysis of over 90,000 urine drug test results, use of the potent fentanyl analogue, parafluorofentanyl, has increased dramatically in the Western U.S.Read More
Rep. Scott Peters, Millennium Health and Others Gather to Urge Awareness on Fentanyl Risks as Students Return to School
SAN DIEGO, Calif. – September 5, 2023 – Fentanyl is a deadly synthetic opioid that has infiltrated every community in America, killing tens of thousands along the way, including many children and teens.Read More
August 23, 2023 – Xylazine has emerged as an adulterating agent in many illicit drug products and can have significant adverse effects, including death. Read More
Millennium Health Study Featured at the College on Problems of Drug Dependence
SAN DIEGO, Calif. – June 20, 2023 – Millennium Health is honored to present at this year’s College of Problems of Drug Dependence (CPDD) annual scientific meeting. Read More
Clinicians Identify Buprenorphine “Spiking” In JAMA Psychiatry Study Supported by Millennium Health Researchers
SAN DIEGO, Calif. – March 22, 2023 – A JAMA Psychiatry study, led by Jarratt D. Pytell, MD, MHS, Department of Medicine, University of Colorado School of Medicine, and co-authored by Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, and Millennium Health researchers calls attention to factors associated with patients who have urine drug test (UDT) samples suggestive of buprenorphine “ADD-IN” (commonly referred to as “spiking”). Read More
Patient Billing
(877) 451-7337
PatientBillingServices@millenniumhealth.com
Monday-Friday 6:00AM-4:00PM PT
Corporate Headquarters
(877) 451-3534
Customer Service
(RADAR® Hotline)
(866) 866-0605
customerservice@millenniumhealth.com
Monday–Friday 5:00AM-5:30PM PT